Report Detail
Global and China Pharma Ophthalmic Market Insights, Forecast to 2026
- RnM4199184 |
- 10 September, 2020 |
- Global |
- 130 Pages |
- QYResearch |
- Pharma & Healthcare
Pharma Ophthalmic market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Pharma Ophthalmic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Pharma Ophthalmic market is segmented into
Retinal disorders drugs
Allergic, inflammatory and infective drugs
Glaucoma drugs
Dry eye drugs
Other ophthalmic drugs
Segment by Application, the Pharma Ophthalmic market is segmented into
Glaucoma
Dry eye syndrome
Retinal diseases
Other ophthalmic indications
Regional and Country-level Analysis
The Pharma Ophthalmic market is analysed and market size information is provided by regions (countries).
The key regions covered in the Pharma Ophthalmic market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Pharma Ophthalmic Market Share Analysis
Pharma Ophthalmic market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pharma Ophthalmic business, the date to enter into the Pharma Ophthalmic market, Pharma Ophthalmic product introduction, recent developments, etc.
The major vendors covered:
Novartis
Allergan
Roche
Valeant
Regeneron
Santen
Bayer
Pfizer
Senju
Akorn
1 Study Coverage
- 1.1 Pharma Ophthalmic Product Introduction
- 1.2 Market Segments
- 1.3 Key Pharma Ophthalmic Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Pharma Ophthalmic Market Size Growth Rate by Type
- 1.4.2 Retinal disorders drugs
- 1.4.3 Allergic, inflammatory and infective drugs
- 1.4.4 Glaucoma drugs
- 1.4.5 Dry eye drugs
- 1.4.6 Other ophthalmic drugs
- 1.5 Market by Application
- 1.5.1 Global Pharma Ophthalmic Market Size Growth Rate by Application
- 1.5.2 Glaucoma
- 1.5.3 Dry eye syndrome
- 1.5.4 Retinal diseases
- 1.5.5 Other ophthalmic indications
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Pharma Ophthalmic Market Size, Estimates and Forecasts
- 2.1.1 Global Pharma Ophthalmic Revenue 2015-2026
- 2.1.2 Global Pharma Ophthalmic Sales 2015-2026
- 2.2 Global Pharma Ophthalmic, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.3 Pharma Ophthalmic Historical Market Size by Region (2015-2020)
- 2.3.1 Global Pharma Ophthalmic Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.3.2 Global Pharma Ophthalmic Retrospective Market Scenario in Revenue by Region: 2015-2020
- 2.4 Pharma Ophthalmic Market Estimates and Projections by Region (2021-2026)
- 2.4.1 Global Pharma Ophthalmic Sales Forecast by Region (2021-2026)
- 2.4.2 Global Pharma Ophthalmic Revenue Forecast by Region (2021-2026)
3 Global Pharma Ophthalmic Competitor Landscape by Players
- 3.1 Global Top Pharma Ophthalmic Sales by Manufacturers
- 3.1.1 Global Pharma Ophthalmic Sales by Manufacturers (2015-2020)
- 3.1.2 Global Pharma Ophthalmic Sales Market Share by Manufacturers (2015-2020)
- 3.2 Global Pharma Ophthalmic Manufacturers by Revenue
- 3.2.1 Global Pharma Ophthalmic Revenue by Manufacturers (2015-2020)
- 3.2.2 Global Pharma Ophthalmic Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Pharma Ophthalmic Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Pharma Ophthalmic Revenue in 2019
- 3.2.5 Global Pharma Ophthalmic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Global Pharma Ophthalmic Price by Manufacturers
- 3.4 Global Pharma Ophthalmic Manufacturing Base Distribution, Product Types
- 3.4.1 Pharma Ophthalmic Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Pharma Ophthalmic Product Type
- 3.4.3 Date of International Manufacturers Enter into Pharma Ophthalmic Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Pharma Ophthalmic Market Size by Type (2015-2020)
- 4.1.1 Global Pharma Ophthalmic Sales by Type (2015-2020)
- 4.1.2 Global Pharma Ophthalmic Revenue by Type (2015-2020)
- 4.1.3 Pharma Ophthalmic Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Pharma Ophthalmic Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Pharma Ophthalmic Sales Forecast by Type (2021-2026)
- 4.2.2 Global Pharma Ophthalmic Revenue Forecast by Type (2021-2026)
- 4.2.3 Pharma Ophthalmic Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Pharma Ophthalmic Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Pharma Ophthalmic Market Size by Application (2015-2020)
- 5.1.1 Global Pharma Ophthalmic Sales by Application (2015-2020)
- 5.1.2 Global Pharma Ophthalmic Revenue by Application (2015-2020)
- 5.1.3 Pharma Ophthalmic Price by Application (2015-2020)
- 5.2 Pharma Ophthalmic Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Pharma Ophthalmic Sales Forecast by Application (2021-2026)
- 5.2.2 Global Pharma Ophthalmic Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Pharma Ophthalmic Price Forecast by Application (2021-2026)
6 China by Players, Type and Application
- 6.1 China Pharma Ophthalmic Market Size YoY Growth 2015-2026
- 6.1.1 China Pharma Ophthalmic Sales YoY Growth 2015-2026
- 6.1.2 China Pharma Ophthalmic Revenue YoY Growth 2015-2026
- 6.1.3 China Pharma Ophthalmic Market Share in Global Market 2015-2026
- 6.2 China Pharma Ophthalmic Market Size by Players (International and Local Players)
- 6.2.1 China Top Pharma Ophthalmic Players by Sales (2015-2020)
- 6.2.2 China Top Pharma Ophthalmic Players by Revenue (2015-2020)
- 6.3 China Pharma Ophthalmic Historic Market Review by Type (2015-2020)
- 6.3.1 China Pharma Ophthalmic Sales Market Share by Type (2015-2020)
- 6.3.2 China Pharma Ophthalmic Revenue Market Share by Type (2015-2020)
- 6.3.3 China Pharma Ophthalmic Price by Type (2015-2020)
- 6.4 China Pharma Ophthalmic Market Estimates and Forecasts by Type (2021-2026)
- 6.4.1 China Pharma Ophthalmic Sales Forecast by Type (2021-2026)
- 6.4.2 China Pharma Ophthalmic Revenue Forecast by Type (2021-2026)
- 6.4.3 China Pharma Ophthalmic Price Forecast by Type (2021-2026)
- 6.5 China Pharma Ophthalmic Historic Market Review by Application (2015-2020)
- 6.5.1 China Pharma Ophthalmic Sales Market Share by Application (2015-2020)
- 6.5.2 China Pharma Ophthalmic Revenue Market Share by Application (2015-2020)
- 6.5.3 China Pharma Ophthalmic Price by Application (2015-2020)
- 6.6 China Pharma Ophthalmic Market Estimates and Forecasts by Application (2021-2026)
- 6.6.1 China Pharma Ophthalmic Sales Forecast by Application (2021-2026)
- 6.6.2 China Pharma Ophthalmic Revenue Forecast by Application (2021-2026)
- 6.6.3 China Pharma Ophthalmic Price Forecast by Application (2021-2026)
7 North America
- 7.1 North America Pharma Ophthalmic Market Size YoY Growth 2015-2026
- 7.2 North America Pharma Ophthalmic Market Facts & Figures by Country
- 7.2.1 North America Pharma Ophthalmic Sales by Country (2015-2020)
- 7.2.2 North America Pharma Ophthalmic Revenue by Country (2015-2020)
- 7.2.3 U.S.
- 7.2.4 Canada
8 Europe
- 8.1 Europe Pharma Ophthalmic Market Size YoY Growth 2015-2026
- 8.2 Europe Pharma Ophthalmic Market Facts & Figures by Country
- 8.2.1 Europe Pharma Ophthalmic Sales by Country
- 8.2.2 Europe Pharma Ophthalmic Revenue by Country
- 8.2.3 Germany
- 8.2.4 France
- 8.2.5 U.K.
- 8.2.6 Italy
- 8.2.7 Russia
9 Asia Pacific
- 9.1 Asia Pacific Pharma Ophthalmic Market Size YoY Growth 2015-2026
- 9.2 Asia Pacific Pharma Ophthalmic Market Facts & Figures by Country
- 9.2.1 Asia Pacific Pharma Ophthalmic Sales by Region (2015-2020)
- 9.2.2 Asia Pacific Pharma Ophthalmic Revenue by Region
- 9.2.3 China
- 9.2.4 Japan
- 9.2.5 South Korea
- 9.2.6 India
- 9.2.7 Australia
- 9.2.8 Taiwan
- 9.2.9 Indonesia
- 9.2.10 Thailand
- 9.2.11 Malaysia
- 9.2.12 Philippines
- 9.2.13 Vietnam
10 Latin America
- 10.1 Latin America Pharma Ophthalmic Market Size YoY Growth 2015-2026
- 10.2 Latin America Pharma Ophthalmic Market Facts & Figures by Country
- 10.2.1 Latin America Pharma Ophthalmic Sales by Country
- 10.2.2 Latin America Pharma Ophthalmic Revenue by Country
- 10.2.3 Mexico
- 10.2.4 Brazil
- 10.2.5 Argentina
11 Middle East and Africa
- 11.1 Middle East and Africa Pharma Ophthalmic Market Size YoY Growth 2015-2026
- 11.2 Middle East and Africa Pharma Ophthalmic Market Facts & Figures by Country
- 11.2.1 Middle East and Africa Pharma Ophthalmic Sales by Country
- 11.2.2 Middle East and Africa Pharma Ophthalmic Revenue by Country
- 11.2.3 Turkey
- 11.2.4 Saudi Arabia
- 11.2.5 U.A.E
12 Company Profiles
- 12.1 Novartis
- 12.1.1 Novartis Corporation Information
- 12.1.2 Novartis Description and Business Overview
- 12.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
- 12.1.4 Novartis Pharma Ophthalmic Products Offered
- 12.1.5 Novartis Recent Development
- 12.2 Allergan
- 12.2.1 Allergan Corporation Information
- 12.2.2 Allergan Description and Business Overview
- 12.2.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
- 12.2.4 Allergan Pharma Ophthalmic Products Offered
- 12.2.5 Allergan Recent Development
- 12.3 Roche
- 12.3.1 Roche Corporation Information
- 12.3.2 Roche Description and Business Overview
- 12.3.3 Roche Sales, Revenue and Gross Margin (2015-2020)
- 12.3.4 Roche Pharma Ophthalmic Products Offered
- 12.3.5 Roche Recent Development
- 12.4 Valeant
- 12.4.1 Valeant Corporation Information
- 12.4.2 Valeant Description and Business Overview
- 12.4.3 Valeant Sales, Revenue and Gross Margin (2015-2020)
- 12.4.4 Valeant Pharma Ophthalmic Products Offered
- 12.4.5 Valeant Recent Development
- 12.5 Regeneron
- 12.5.1 Regeneron Corporation Information
- 12.5.2 Regeneron Description and Business Overview
- 12.5.3 Regeneron Sales, Revenue and Gross Margin (2015-2020)
- 12.5.4 Regeneron Pharma Ophthalmic Products Offered
- 12.5.5 Regeneron Recent Development
- 12.6 Santen
- 12.6.1 Santen Corporation Information
- 12.6.2 Santen Description and Business Overview
- 12.6.3 Santen Sales, Revenue and Gross Margin (2015-2020)
- 12.6.4 Santen Pharma Ophthalmic Products Offered
- 12.6.5 Santen Recent Development
- 12.7 Bayer
- 12.7.1 Bayer Corporation Information
- 12.7.2 Bayer Description and Business Overview
- 12.7.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
- 12.7.4 Bayer Pharma Ophthalmic Products Offered
- 12.7.5 Bayer Recent Development
- 12.8 Pfizer
- 12.8.1 Pfizer Corporation Information
- 12.8.2 Pfizer Description and Business Overview
- 12.8.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 12.8.4 Pfizer Pharma Ophthalmic Products Offered
- 12.8.5 Pfizer Recent Development
- 12.9 Senju
- 12.9.1 Senju Corporation Information
- 12.9.2 Senju Description and Business Overview
- 12.9.3 Senju Sales, Revenue and Gross Margin (2015-2020)
- 12.9.4 Senju Pharma Ophthalmic Products Offered
- 12.9.5 Senju Recent Development
- 12.10 Akorn
- 12.10.1 Akorn Corporation Information
- 12.10.2 Akorn Description and Business Overview
- 12.10.3 Akorn Sales, Revenue and Gross Margin (2015-2020)
- 12.10.4 Akorn Pharma Ophthalmic Products Offered
- 12.10.5 Akorn Recent Development
- 12.11 Novartis
- 12.11.1 Novartis Corporation Information
- 12.11.2 Novartis Description and Business Overview
- 12.11.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
- 12.11.4 Novartis Pharma Ophthalmic Products Offered
- 12.11.5 Novartis Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Pharma Ophthalmic Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Pharma Ophthalmic Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Pharma Ophthalmic. Industry analysis & Market Report on Pharma Ophthalmic is a syndicated market report, published as Global and China Pharma Ophthalmic Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of Pharma Ophthalmic market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
